重视风湿免疫病的肝脏表现

王程瑶, 刘燕鹰

PDF(615 KB)
PDF(615 KB)
临床肝胆病杂志 ›› 2025, Vol. 41 ›› Issue (05) : 801-805. DOI: 10.12449/JCH250501
述评

重视风湿免疫病的肝脏表现

作者信息 +

Recognizing hepatic manifestations in rheumatic diseases

Author information +
History +

摘要

肝脏是风湿免疫病最常受累的器官之一。风湿免疫病患者的肝脏病变可由疾病直接累及肝脏、合并其他原发性肝病或药物相关肝损伤等多种因素导致。当患者出现肝功能异常时,应仔细鉴别病因。对于病因不明的肝损伤,应常规检测自身抗体,以早期识别潜在的自身免疫性肝病。若病因仍不明确,建议在条件允许的情况下进行肝穿刺活检以确诊。在积极治疗风湿免疫病的同时,应密切监测肝功能变化,避免使用可能加重肝损伤的药物,尤其是肝毒性较强的抗风湿药物,并根据患者的具体情况调整治疗方案,降低肝损伤风险,优化长期预后。

Abstract

The liver is one of the organs most commonly affected by rheumatic diseases. Hepatic abnormalities in patients with rheumatic diseases can result from a variety of factors,including direct liver involvement by the disease itself,coexistence with primary liver disease,and drug-induced liver injury. When liver indicators are abnormal,a thorough differential diagnosis is required. For unexplained liver dysfunction,routine testing for autoantibodies should be performed to facilitate early identification of underlying autoimmune liver disease. If the etiology remains unclear,a liver biopsy is recommended for a final diagnosis if feasible. Alongside active management of rheumatic diseases,it is necessary to closely monitor liver function,avoid the use of agents that may exacerbate hepatic damage,particularly anti-rheumatic drugs with strong hepatotoxicity,and tailor treatment strategies according to personal specific conditions,so as to minimize liver damage and improve long-term outcome.

关键词

风湿性疾病 / 肝功能不全 / 自身免疫性肝病

Key words

Rheumatic Diseases / Hepatic Insufficiency / Autoimmune Liver Diseases

引用本文

导出引用
王程瑶 , 刘燕鹰. 重视风湿免疫病的肝脏表现. 临床肝胆病杂志. 2025, 41(05): 801-805 https://doi.org/10.12449/JCH250501
WANG Chengyao, LIU Yanying. Recognizing hepatic manifestations in rheumatic diseases[J]. Journal of Clinical Hepatol. 2025, 41(05): 801-805 https://doi.org/10.12449/JCH250501

参考文献

[1]
SZEKANECZ Z, MCINNES IB, SCHETT G, et al. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases[J]. Nat Rev Rheumatol, 2021, 17(10): 585-595. DOI: 10.1038/s41584-021-00652-9.
[2]
GEBRESELASSIE A, ADULI F, HOWELL CD. Rheumatologic diseases and the liver[J]. Clin Liver Dis, 2019, 23(2): 247-261. DOI: 10.1016/j.cld.2018.12.007.
[3]
PODGÓRSKA J, WEREL P, KLAPACZYŃSKI J, et al. Liver involvement in rheumatic diseases[J]. Reumatologia, 2020, 58(5): 289-296. DOI: 10.5114/reum.2020.99782.
[4]
WANG CR, TSAI HW. Autoimmune liver diseases in systemic rheumatic diseases[J]. World J Gastroenterol, 2022, 28(23): 2527-2545. DOI: 10.3748/wjg.v28.i23.2527.
[5]
Chinese Rheumatology Association, Chinese Medical Association; Rheumatology and Immunology Physician Branch, Chinese Medical Doctor Association; Branch Rheumatology, China Association of Chinese Medicine, et al. Chinese expert consensus on diagnosis and treatment of antirheumatic drug-induced liver injury (2024)[J]. Chin J Intern Med, 2024, 63(8): 743-761. DOI: 10.3760/cma.j.cn112138-20240418-00248.
中华医学会风湿病学分会, 中国医师协会风湿免疫科医师分会, 中华中医药学会风湿病分会,等. 抗风湿病药物性肝损伤诊治中国专家共识(2024年版)[J]. 中华内科杂志, 2024, 63(8): 743-761. DOI: 10.3760/cma.j.cn112138-20240418-00248.
[6]
ANDRADE RJ, AITHAL GP, BJÖRNSSON ES, et al. EASL Clinical Practice Guidelines: Drug-induced liver injury[J]. J Hepatol, 2019, 70(6): 1222-1261. DOI: 10.1016/j.jhep.2019.02.014.
[7]
YOUNOSSI Z, HENRY L. Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality[J]. Gastroenterology, 2016, 150(8): 1778-1785. DOI: 10.1053/j.gastro.2016.03.005.
[8]
CHOWDHARY VR, CROWSON CS, POTERUCHA JJ, et al. Liver involvement in systemic lupus erythematosus: Case review of 40 patients[J]. 2008, 35(11): 2159-2164. DOI: 10.3899/jrheum.080336.
[9]
GONZÁLEZ-REGUEIRO JA, CRUZ-CONTRERAS M, MERAYO-CHALICO J, et al. Hepatic manifestations in systemic lupus erythematosus[J]. Lupus, 2020, 29(8): 813-824. DOI: 10.1177/0961203320923398.
[10]
PIGA M, VACCA A, PORRU G, et al. Liver involvement in systemic lupus erythematosus: Incidence, clinical course and outcome of lupus hepatitis[J]. Clin Exp Rheumatol, 2010, 28(4): 504-510.
[11]
SOLELA G, DABA M. Budd-Chiari syndrome as an initial presentation of systemic lupus erythematosus associated with antiphospholipid syndrome: A case report with review of the literature[J]. Open Access Rheumatol, 2023, 15: 139-143. DOI: 10.2147/OARRR.S425535.
[12]
SUN Y, ZHANG WC, LI BS, et al. The coexistence of Sjögren’s syndrome and primary biliary cirrhosis: A comprehensive review[J]. Clin Rev Allergy Immunol, 2015, 48(2-3): 301-315. DOI: 10.1007/s12016-015-8471-1.
[13]
XIAO QF, FEI YY. The relationship between primary biliary cholangitis and Sjögren’s syndrome[J]. J Clin Hepatol, 2021, 37(10): 2262-2268. DOI: 10.3969/j.issn.1001-5256.2021.10.002.
肖秋凤, 费允云. 原发性胆汁性胆管炎与干燥综合征的关系[J]. 临床肝胆病杂志, 2021, 37(10): 2262-2268. DOI: 10.3969/j.issn.1001-5256.2021.10.002.
[14]
FORBES A, MARIE I. Gastrointestinal complications: The most frequent internal complications of systemic sclerosis[J]. Rheumatology (Oxford), 2009, 48(Suppl 3): iii36-iii39. DOI: 10.1093/rheumatology/ken485.
[15]
LIBERAL R, GRANT CR, SAKKAS L, et al. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis[J]. Clin Res Hepatol Gastroenterol, 2013, 37(6): 572-585. DOI: 10.1016/j.clinre.2013.04.005.
[16]
NAGASHIMA T, KAMATA Y, IWAMOTO M, et al. Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis[J]. Rheumatol Int, 2019, 39(5): 901-909. DOI: 10.1007/s00296-019-04255-2.
[17]
KUROKAWA M, HIOKI T, AOYAGI T, et al. Clinicopathologic features of adult-onset Still’s disease complicated by severe liver injury[J]. Intern Med, 2024, 63(4): 503-511. DOI: 10.2169/internalmedicine.2043-23.
[18]
CHI HH, WANG ZH, MENG JF, et al. A cohort study of liver involvement in patients with adult-onset Still’s disease: Prevalence, characteristics and impact on prognosis[J]. Front Med (Lausanne), 2020, 7: 621005. DOI: 10.3389/fmed.2020.621005.
[19]
CHEN SY, ZHAO XY. Clinicopathological characteristics and key therapeutic options for liver involvement with vasculitis[J]. Chin J Hepatol, 2023, 31(9): 905-909. DOI: 10.3760/cma.j.cn501113-20230813-00053.
陈苏云, 赵新颜. 血管炎肝脏受累的临床病理特点及治疗要点[J]. 中华肝脏病杂志, 2023, 31(9): 905-909. DOI: 10.3760/cma.j.cn501113-20230813-00053.
[20]
WANG TQ, LIU YY. Advances in diagnosis and treatment of IgG4-related hepatobiliary and pancreatic diseases[J]. J Clin Hepatol, 2022, 38(4): 762-766. DOI: 10.3969/j.issn.1001-5256.2022.04.006.
王天琪, 刘燕鹰. IgG4相关肝胆胰疾病诊疗进展[J]. 临床肝胆病杂志, 2022, 38(4): 762-766. DOI: 10.3969/j.issn.1001-5256.2022.04.006.
[21]
FIGUS FA, PIGA M, AZZOLIN I, et al. Rheumatoid arthritis: Extra-articular manifestations and comorbidities[J]. Autoimmun Rev, 2021, 20(4): 102776. DOI: 10.1016/j.autrev.2021.102776.
[22]
RADOVANOVIĆ-DINIĆ B, TEŠIĆ-RAJKOVIĆ S, ZIVKOVIC V, et al. Clinical connection between rheumatoid arthritis and liver damage[J]. Rheumatol Int, 2018, 38(5): 715-724. DOI: 10.1007/s00296-018-4021-5.
[23]
MIHAI IR, REZUS C, BURLUI MA, et al. Autoimmune liver diseases and rheumatoid arthritis-Is there an etiopathogenic link?[J]. Int J Mol Sci, 2024, 25(7): 3848. DOI: 10.3390/ijms25073848.
[24]
ZAMANI M, ALIZADEH-TABARI S, CHITKARA P, et al. Prevalence of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: A systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2023, 21(11): 2789-2796. DOI: 10.1016/j.cgh.2023.02.021.
[25]
THORNE C, UROWITZ MB, WANLESS I, et al. Liver disease in Felty’s syndrome[J]. Am J Med, 1982, 73(1): 35-40. DOI: 10.1016/0002-9343(82)90921-4.
[26]
TOLEDO-IBELLES P, GUTIÉRREZ-VIDAL R, CALIXTO-TLACOMULCO S, et al. Hepatic accumulation of hypoxanthine: A link between hyperuricemia and nonalcoholic fatty liver disease[J]. Arch Med Res, 2021, 52(7): 692-702. DOI: 10.1016/j.arcmed.2021.04.005.
[27]
ORTOLAN A, LORENZIN M, TADIOTTO G, et al. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients[J]. Clin Rheumatol, 2019, 38(10): 2843-2850. DOI: 10.1007/s10067-019-04646-7.
[28]
LIM LY, OON HH. Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis[J]. Exp Dermatol, 2023, 32(8): 1246-1252. DOI: 10.1111/exd.14766.
[29]
ROBINSON AC, TEELING M, CASEY EB. Hepatic function in ankylosing spondylitis[J]. Ann Rheum Dis, 1983, 42(5): 550-552. DOI: 10.1136/ard.42.5.550.
[30]
KUNG YY, TSAI CY, TSAI YY, et al. Enthesopathy in a case of primary biliary cirrhosis with positive HLA-B27[J]. Clin Exp Rheumatol, 1997, 15(6): 708-709.
[31]
WU CY, LI MC, DUAN XW, et al. Clinical characteristics of patients with rheumatic diseases and abnormal liver function[J]. Chin J Intern Med, 2023, 62(9): 1102-1113. DOI: 10.3760/cma.j.cn112138-20220909-00669.
吴婵媛, 李慕聪, 段新旺, 等. 风湿免疫病合并肝功能异常患者的临床特征[J]. 中华内科杂志, 2023, 62(9): 1102-1113. DOI: 10.3760/cma.j.cn112138-20220909-00669.
[32]
ZHU YL, YU HH. Diagnosis and treatment of autoimmune hepatitis-primary biliary cholangitis overlap syndrome[J]. Adv Clin Med, 2023, 13(3): 4678-4685. DOI: 10.12677/ACM.2023.133671.
朱玉兰, 俞慧宏. 自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征的诊疗[J]. 临床医学进展, 2023, 13(3): 4678-4685. DOI: 10.12677/ACM.2023.133671.
[33]
MANNS MP, LOHSE AW, VERGANI D. Autoimmune hepatitis-update 2015[J]. J Hepatol, 2015, 62(1): S100-S111. DOI: 10.1016/j.jhep.2015.03.005.

作者贡献声明

王程瑶负责文献检索,撰写论文,整理内容;刘燕鹰负责整体构思与写作指导,参与文章内容审阅与修订,完成最终定稿。

评论

PDF(615 KB)

Accesses

Citation

Detail

段落导航
相关文章

/